12679215

Source:http://linkedlifedata.com/resource/pubmed/id/12679215

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0126174, umls-concept:C0857121, umls-concept:C0961485, umls-concept:C1609177
pubmed:issue	7
pubmed:dateCreated	2003-4-7
pubmed:abstractText	The purpose of this study was to evaluate the efficacy and tolerability of monotherapy with the selective aldosterone blocker eplerenone in both black and white patients with hypertension.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12679215-12679216, http://linkedlifedata.com/resource/pubmed/commentcorrection/12679215-13678945
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone, http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Losartan, http://linkedlifedata.com/resource/pubmed/chemical/Renin, http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone, http://linkedlifedata.com/resource/pubmed/chemical/eplerenone
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0735-1097
pubmed:author	pubmed-author:FlackJohn MJM, pubmed-author:GarthwaiteSusanS, pubmed-author:KleimanJay HJH, pubmed-author:KrauseScott LSL, pubmed-author:OparilSuzanneS, pubmed-author:PrattJ HowardJH, pubmed-author:RonikerBarbaraB, pubmed-author:SaundersElijahE, pubmed-author:WorkmanDianeD, pubmed-author:YangYonghongY
pubmed:issnType	Print
pubmed:day	2
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1148-55
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12679215-Adult, pubmed-meshheading:12679215-African Continental Ancestry Group, pubmed-meshheading:12679215-Aldosterone, pubmed-meshheading:12679215-Aldosterone Antagonists, pubmed-meshheading:12679215-Analysis of Variance, pubmed-meshheading:12679215-Angiotensin Receptor Antagonists, pubmed-meshheading:12679215-Antihypertensive Agents, pubmed-meshheading:12679215-Blood Pressure, pubmed-meshheading:12679215-Double-Blind Method, pubmed-meshheading:12679215-European Continental Ancestry Group, pubmed-meshheading:12679215-Female, pubmed-meshheading:12679215-Humans, pubmed-meshheading:12679215-Hypertension, pubmed-meshheading:12679215-Losartan, pubmed-meshheading:12679215-Male, pubmed-meshheading:12679215-Middle Aged, pubmed-meshheading:12679215-Renin, pubmed-meshheading:12679215-Renin-Angiotensin System, pubmed-meshheading:12679215-Spironolactone, pubmed-meshheading:12679215-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.
pubmed:affiliation	Department of Internal Medicine, Wayne State University, Detroit, Michigan 48201, USA. JFlack@intmed.wayne.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study